NovaBay Pharmaceuticals, Inc.  

(Public, NYSEMKT:NBY)   Watch this stock  
Find more results for nby
0.790
+0.010 (1.28%)
Real-time:   3:09PM EDT
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 0.77 - 0.80
52 week 0.42 - 1.30
Open 0.78
Vol / Avg. 288,968.00/457,470.00
Mkt cap 47.87M
P/E     -
Div/yield     -
EPS -0.31
Shares 61.20M
Beta 0.50
Inst. own 9%
Jul 30, 2015
Q2 2015 NovaBay Pharmaceuticals Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
May 28, 2015
NovaBay Pharmaceuticals Inc at SeeThruEquity LLC Microcap Investor Conference
May 14, 2015
Q1 2015 NovaBay Pharmaceuticals Inc Earnings Release
Mar 26, 2015
Q4 2014 NovaBay Pharmaceuticals Inc Earnings Call
Mar 26, 2015
Q4 2014 NovaBay Pharmaceuticals Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -862.45% -1441.56%
Operating margin -866.36% -1601.33%
EBITD margin - -1579.32%
Return on average assets -237.20% -131.06%
Return on average equity -931.25% -293.21%
Employees 32 -
CDP Score - -

Address

5980 Horton St Ste 550
EMERYVILLE, CA 94608-2045
United States - Map
+1-510-8998800 (Phone)
+1-510-2250371 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

NovaBay Pharmaceuticals, Inc. (NovaBay) is a biopharmaceutical company. It is focused on addressing the unmet therapeutic needs of the global, topical anti-infective market with two product categories. These include its three commercial products containing Neutrox (its proprietary hypochlorous acid solution), such as, Avenova for the eye care market, NeutroPhase for wound care, and CelleRx for the dermatology market, and its clinical stage Aganocide compounds. Consisting of 0.03% Neutrox, NeutroPhase may be used to cleanse and remove microorganisms from any type of acute or chronic wound, and can be used with any type of wound care modality. Cleansing with Avenova removes microorganisms and debris from the skin on eyelids and lashes without burning or irritation. CelleRx (0.015% Neutrox) is a cleansing solution, which is effective for post laser resurfacing, chemical peels and other cosmetic surgery procedures.

Officers and directors

Mark M. Sieczkarek Chairman of the Board
Age: 60
Bio & Compensation  - Reuters
Ramin Najafi Ph.D. President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Thomas J. Paulson Chief Financial Officer, Treasurer, Secretary, IR Contact Officer
Age: 68
Bio & Compensation  - Reuters
Russell A. Hoon Senior Vice President - Advanced wood care
Age: 62
Bio & Compensation  - Reuters
David W. Stroman Ph.D. Senior Vice President - Ophthalmic Product Development
Age: 70
Bio & Compensation  - Reuters
Roy J. Wu Senior Vice President - Business & Corporate Development
Age: 60
Bio & Compensation  - Reuters
Xinzhou Li Director
Age: 51
Bio & Compensation  - Reuters
Massimo Radaelli Ph.D. Director
Age: 57
Bio & Compensation  - Reuters
Charles J. Cashion Independent Director
Age: 64
Bio & Compensation  - Reuters
Paul E. Freiman Independent Director
Age: 80
Bio & Compensation  - Reuters